ACCESS Newswire

Triloc Films Studio Inc.

Share
Thought-Provoking Movie 'MAHAYOGI: Highway 1 to Oneness' About a Hero’s Quest to Unite the World to Give 50% of Proceeds to Global Charities

In a World Out of Balance, Film Represents the Zenith of Humanism - Oneness - to Bring the World Closer as One and Foster Unity Around the Globe

LOS ANGELES, CA / ACCESSWIRE / November 23, 2023 / "MAHAYOGI: HIGHWAY 1 TO ONENESS," a new film from Triloc Films Studio Inc., emerges as a guiding light, poised to infuse all humanity with love, tranquility, peace and oneness. Written and directed by Rajan Luthra, an entrepreneur, philanthropist, and visionary, the film offers humanity a platform for unity amid the rapid pace of our civilization. This concept of Oneness transcends religious boundaries, fostering a collective consciousness deeply connected to the divine.

To view this piece of content from www.accesswire.com, please give your consent at the top of this page.

Rajan Luthra's Noble Pursuits/The Genesis of 'Mahayogi':

Rajan Luthra's unwavering dedication reaches its zenith in the creation of "Mahayogi: Highway 1 to Oneness." This film represents the zenith of humanism - Oneness. Rajan Luthra's relentless commitment to this project stems from his conviction that Oneness has the power to reshape humanity, bridging divides and sowing the seeds of harmonious coexistence.

mahayogi | One Dollar Media

His latest venture, "One Dollar Media," is making waves. This groundbreaking online platform will set to house an extensive collection of Rajan Luthra's films and media projects. By collaborating with Hollywood's esteemed Triloc Films Studio, this platform will feature an array of films and documentaries, and bridge the gap between Hollywood and Bollywood.

RAJANLUTHRA (rajanluthra1.carrd.co)

Unveiling One Dollar Media: Imminent is the global launch of One Dollar Media - an over-the-top platform. A remarkable aspect of this venture is that a part of the profits generated will be dedicated to the noble cause championed by Help Foundations Group. This financial contribution will aid in eradicating poverty, bolstering health initiatives, spreading the doctrine of unity (Oneness), and broadcasting positive messages on a global scale.

(66) Actor/Producer Rajan Luthra's Grand Music & Trailer Launch Movie MAHAYOGI - YouTube

"A Cinematic Quest for Oneness: Rajan Luthra's 'Mahayogi HWY 1'" (deccanherald.com)

Movie Song: https://www.youtube.com/watch?v=RaMedpAFPXA
Movie Trailer: https://www.youtube.com/watch?v=0J0CLrGWLY0
Help Foundation Video: https://www.youtube.com/watch?v=g5m3ihFKsVU

A World Out of Balance: In a world propelled by ceaseless momentum, the value of contemplation and unity is often overshadowed. This disconnect is evident in events such as ethnic strife in Manipur and communal tensions in various parts of India. Rajan Luthra keenly perceives the absence of human unity within diverse groups, leading to instances of the degradation of human dignity.

A Quest for Equilibrium: The world yearns for balance, and Rajan Luthra endeavours to provide it with his life's trajectory intertwined with pivotal historical events. His portrayal of Mahayogi encapsulates his vision for global transformation - a transformation driven by love, unity, consciousness, and purity. This journey, rooted in unwavering faith, aims to reawaken empathy within humanity.

A Plea for Unity: Rajan Luthra's resounding call - "Be One with Everyone. There is ONE within Everyone."

Spreading the Message: Rajan Luthra implores individuals from all walks of life - celebrities, sportsmen, personalities, politicians, philanthropists, spiritual leaders, corporate magnates, influencers, and ordinary individuals - to rally behind the message of Oneness. He recognizes the pivotal role of film in reshaping consciousness for inner awakening to finding oneself within and steering the world toward unity, peace and love and Oneness.

Contact Information:

Rajan Luthra
CEO
info@trilocfilms.com
424-239-4142

SOURCE: Triloc Films Studio Inc.

To view this piece of content from stats.newswire.com, please give your consent at the top of this page.

View source version on accesswire.com:
https://www.accesswire.com/809236/thought-provoking-movie-mahayogi-highway-1-to-oneness-about-a-heros-quest-to-unite-the-world-to-give-50-of-proceeds-to-global-charities

To view this piece of content from www.accesswire.com, please give your consent at the top of this page.

About ACCESS Newswire

DK

Subscribe to releases from ACCESS Newswire

Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from ACCESS Newswire

SK tes Launches New Circular IT Facility in Shannon, Expanding Ireland’s Role in Global Sustainable Tech Services24.4.2025 09:30:00 CEST | Press release

SHANNON, IE / ACCESS Newswire / April 24, 2025 / SK tes, a global leader in sustainable IT asset disposition (ITAD) and technology lifecycle services, has announced plans to open a new 36,000 square foot purpose-built facility in Shannon, marking a major vote of confidence in Ireland's thriving data and technology sector. The new facility will deliver comprehensive ITAD, data center decommissioning, and technology lifecycle management services to some of Ireland's largest enterprises, including hyperscale data center operators, while supporting national sustainability and circular economy goals. It will also create over 25 skilled jobs in one of the country's fastest-growing tech regions. "Ireland is at the forefront of Europe's digital economy, and our investment in Shannon reinforces our commitment to helping Irish companies manage technology securely, sustainably, and at scale," said Eric Ingebretsen, Chief Commercial Officer at SK tes. "This facility will allow us to meet the uniqu

Sauce Labs Launches Industry-First Enterprise Scale iOS 18 Testing on Sauce Labs Virtual Device Cloud, Boosting Test Speeds up to 40%24.4.2025 08:00:00 CEST | Press release

Leading test automation platform, powering development for over 300,000 active users and having executed more than 8 billion tests, enables developers and QA teams to ensure app quality on Apple's latest OS with unprecedented performance and scale. SAN FRANCISCO, CA / ACCESS Newswire / April 24, 2025 / Sauce Labs Inc., the leading platform for continuous quality, trusted by dev teams around the world to deliver apps users love, today announced the general availability of iOS 18 testing on its Virtual Device Cloud (VDC). Leveraging its new, high-performance Apple Silicon cloud infrastructure, Sauce Labs offers the market's most scalable enterprise-ready solution for automated mobile app and web testing on iOS 17.5, iOS 18, and beyond, enabling teams to execute tests up to 40% faster compared to previous versions. This launch addresses the critical need for timely testing support driven by Apple's transition to its proprietary Apple Silicon architecture and the rapid adoption rate of new

Introducing NUGEN(R) HLD-CD by Arxada: A Game-Changer in Healthcare Disinfection24.4.2025 07:00:00 CEST | Press release

Delivering Effective Germ Control in Five Minutes BASEL, CH / ACCESS Newswire / April 24, 2025 / Arxada, a global leader in specialty chemicals and innovative solutions, announces the launch of NUGEN® HLD-CD, a revolutionary healthcare disinfectant. This game-changing solution disinfects medical devices in just five minutes, ensuring that even the most resilient microorganisms, which can withstand harsh conditions, are destroyed.* NUGEN® HLD-CD is designed to meet the rigorous demands of healthcare environments. Its broad efficacy spectrum and short contact times make it suitable for all critical areas, including operating rooms, isolation areas, and intensive care units where speed and safety are essential. "We are excited to introduce NUGEN® HLD-CD to the healthcare market," said Uwe Holland, Head of Professional Hygiene EMEA at Arxada. "This solution is a game-changer in disinfection technology for healthcare facilities, providing professionals with a powerful means to improve patie

TCL Introduces the TCL T6C-UK Fire TV Series with QLED 4K, HDR PRO, and Freely23.4.2025 07:30:00 CEST | Press release

LONDON, UNITED KINGDOM / ACCESS Newswire / April 23, 2025 / TCL, the leading consumer electronics brand and the world's second-largest TV brand as well as an official sponsor of the Olympic Games, is proud to announce the launch of its highly anticipated T6C-UK TV series. The new range offers screen sizes from 43" to 85", ensuring there is a perfect option for every home. Featuring QLED technology, 4K resolution, and an intuitive Fire TV experience, the T6C-UK series offers exceptional picture quality, seamless content access, and smart functionality. The TCL T6C-UK series comes Freely-enabled, offering a seamless way to enjoy live and on-demand TV - all in one place and completely free. With Freely built-in, users can access their favourite streaming apps at the click of a button, eliminating the need to switch between platforms. From major channels to must-watch shows, everything is easily accessible from a single, intuitive home screen. Powered by Fire TV, the T6C-UK series also fea

BioNxt Solutions Prepares for Human Bioequivalence Study For MS23.4.2025 03:05:00 CEST | Press release

VANCOUVER, BC / ACCESS Newswire / April 23, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery systems, is pleased to report advanced preparation for its human bioequivalence study for its lead Multiple Sclerosis (MS) treatment. BioNxt's lead product, BNT23001, is a proprietary sublingual thin-film formulation of Cladribine for the treatment of MS. Preclinical studies, as reported in internal research data and third-party evaluations, have demonstrated high absorption rates and bioequivalence compared to existing oral tablet therapies. The Company has purchased Cladribine active pharmaceutical ingredient which is necessary to complete the technology transfer process with Gen-Plus, its European Contract Research and Development Organization (CRDO), in Munich, Germany. Once commenced, the bioequivalence study is relatively short, scheduled for less than 30 days from start to finish. T

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye